Crohn's disease unmasked following etanercept treatment for ankylosing spondylitis

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Jethwa, H ^a   Mann, S ^a  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEMICOLECTOMY; HISTOLOGY; HUMAN; HUMAN TISSUE; ILEOCECAL MASS; LAPAROTOMY; LARGE INTESTINE TUMOR; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SPINE RADIOGRAPHY; TREATMENT INDICATION;

EID: 84880115070     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-009166     Document Type: Article

References (10)

1. Haraoui B, Krelenbaum M. Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action. Semin Arthritis Rheum 2009;39:176-81.
2. Womeldorph C, Goldkind L. Etanercept and inflammatory bowel disease: friend or foe. In: American College of Gastroenterology. No. 538, 69th Annual meeting of the American College of Gastroenterology, Orlando, FA, 31 October-3 November 2004, USA. London: Blackwell Publishing, 2004.
3. Brandt J, Listing J, Haibel H, et al. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis. Rheumatology 2005;44:342 -8.
4. Davis JC Jr, Van Der Heijde D, Braun J, et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003;48:3230-6. (Pubitemid 37409337)
5. Song IH, Appel H, Haibel H, et al. New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept. J Rheum 2008;35:532-6. (Pubitemid 351374434)
6. Bashyam M, Vlahos I, Jones H, et al. Severe peri-anal Crohn's disease developing while on etanercept for ankylosing spondylitis. Gastroenterol Today 2012;22:94-6.
7. Sandborn WJ, Hanauer SB, Katz S, et al. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2001;121:1088-94. (Pubitemid 33022088)
8. Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 2006;20:451-71. (Pubitemid 43843072)
9. Oh J, Arkfeld DG, Horwitz DA. Development of Crohn's disease in a patient taking etanercept. J Rheumatol 2005;32:752-3. (Pubitemid 40524713)
10. Wiegering V, Morbach H, Dick A, et al. Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int 2010;30:801-4.